Companies
featured
U.S. corporate tax reform should be the top priority in the government's efforts to restore economic growth, FedEx Chairman and CEO Frederick Smith told CNBC.
» Read More
More
-
U.S. corporate tax reform should be the top priority in the government's efforts to restore economic growth, FedEx Chairman and CEO Frederick Smith told CNBC.
-
NEW YORK-- Investment firm Cowen Group Inc. said Friday it is buying Dahlman Rose& Co., a privately held investment bank. Cowen is buying Dahlman Rose with stock but the two firms did not disclose further financial details. Cowen Group shares rose 3 cents to $2.69 Friday and were unchanged in aftermarket trading.
-
NEW YORK-- Shares of Keryx Biopharmaceuticals Inc. more than doubled in value this week even after a steep drop Friday as Wall Street responded enthusiastically to clinical trial data for Zerenex, an experimental treatment for a side effect of kidney disease. The New York company has no approved drugs, and its shares surged 82 percent Monday.
-
NEW YORK-- Shares of some top drug benefits companies were up at the close of trading:. CVSCaremark rose$. 38 or. 7 percent, to $51.58. Express Scripts Holding Co. rose $1.39 or 2.6 percent, to $54.81.
-
NEW YORK-- Shares of some top chemicals companies were up at the close of trading:. Dow Chemical Co. rose$. 39 or 1.2 percent, to $32.59. DuPont Co. rose$. 53 or 1.1 percent, to $47.98.
-
NEW YORK-- Shares of Thermo Fisher Scientific Inc. rose Friday after the maker of scientific instruments posted better-than-expected fourth-quarter earnings and was upgraded by JPMorgan Chase& Co.. THE SPARK: JPMorgan upgraded the shares of the maker of scientific instruments to "Overweight" from "Neutral."
-
NEW YORK-- Shares of The Men's Wearhouse Inc. slipped Friday after a Cowen& Co. analyst downgraded the stock, saying he is concerned about the retailer's sales and its profit margins. Kernan said he now expects Men's Wearhouse to earn $2.76 per share in the current fiscal year, down 8 cents from his previous estimate.
-
NEW YORK-- Chubb Corp. shares hit an all-time high Friday after a Deutsche Bank analyst upgraded the company to "Buy" from "Hold," saying that the company offers the best value for investors among the traditional property and casualty companies.
-
Feb 1- Shares of Pfizer Inc's animal health subsidiary Zoetis Inc, which sells drug products and other services for livestock and pets, jumped 21 percent in their New York Stock Exchange debut on Friday. Shares opened at $31.50 after the Madison, New Jersey- based company's stock was priced at $26, above an expected range of $22 to $25 a share.
-
NEW YORK-- Shares of some top chemicals companies are up at 1 p.m.:. Dow Chemical Co. rose$. 30 or. 9 percent, to $32.50. DuPont Co. rose$. 51 or 1.1 percent, to $47.96.
-
NEW YORK-- Shares of some top big-box retail companies are up at 1 p.m.:. Costco Wholesale Corp. rose $1.63 or 1.6 percent, to $103.97. Wal-Mart Stores Inc. rose$. 40 or. 6 percent, to $70.35.
-
NEW YORK-- Shares of some top drug benefits companies are up at 1 p.m.:. CVSCaremark rose$. 44 or. 9 percent, to $51.64. Express Scripts Holding Co. rose$. 89 or 1.7 percent, to $54.31.
-
Dell Inc. rose 3.2 percent to $13.67 with 31,200,200 shares traded. Facebook Inc. fell 2.1 percent to $30.34 with 52,316,400 shares traded. Intel Corp. rose 1.3 percent to $21.32 with 16,514,900 shares traded.
-
NEW YORK-- A look at New York Stock Exchange 10 most-active stocks at 1 p.m.:. Bank of America Corp. rose 3.1 percent to $11.67 with 97,785,200 shares traded. Boston Scientific Corp. rose 2.3 percent to $7.64 with 19,928,400 shares traded.
-
The EPA wanted 8.7 million gallons in 2012, but actual production was near zero. Separately, renewable-fuel producer Amyris Inc. said Friday that its plant in Brazil made its first commercial shipment of farnesene, which is used in specialty chemicals and fuels. In afternoon trading shares of Amyris Inc. rose 23 cents, or 7.5 percent, to $3.27.
-
*Quarterly sales $11.74 bln, vs view $11.48 bln. Feb 1- Merck& Co Inc's quarterly results beat estimates, but the drugmaker issued a cautious 2013 profit forecast and said it will delay seeking approval for a high-profile osteoporosis drug, sending its shares down 3 percent.
-
Net income for Franklin's fiscal first quarter through Dec. 31 totaled $516.1 million, or $2.42 per share, compared with $480.8 million, or $2.20 per share, a year earlier, the San Mateo, California- based firm said. Investors lauded the results, sending shares of Franklin up $2.09, or 1.5 percent, to $138.97 on the New York Stock Exchange.
-
NEW YORK-- Shares of Brightcove tumbled Friday to their lowest point since going public nearly a year ago as the company's full-year and first-quarter forecasts failed to meet Wall Street's expectations.
-
NEW YORK-- Shares of Eastman Chemical climbed to an all-time high on Friday after the specialty chemical company's fourth-quarter adjusted earnings met Wall Street's view and it raised its 2013 earnings forecast. THE SPARK: After the market closed Thursday, Eastman Chemical Co. reported a fourth-quarter loss of $54 million, or 35 cents per share.
-
NEW YORK-- Shares of some top big-box retail companies are up at 10 a.m.:. Costco Wholesale Corp. rose$. 88 or. 9 percent, to $103.22. Wal-Mart Stores Inc. rose$. 32 or. 5 percent, to $70.27.